News

This poster describes the impact of timing of next-generation sequencing (NGS) on therapy selection in lung cancer.

Dienstmann R et al, Timing of next-generation sequencing (NGS) relative to first line therapy in lung cancer: insights from the global WAYFIND-R registry,

ISPOR Europe 2024, RWD111

This poster describes next-generation sequencing (NGS) practice in the most common cancer types.

Le Tourneau C., et al., Next-generation sequencing (NGS) in routine care: Medical practice in 24 countries from the pan-cancer WAYFIND-R registry

ESMO 2024, poster 88P

Academic researchers can submit their own research proposals to request access to data from the WAYFIND-R registry database.

We are delighted to inform that investigators and academic researchers can request access to the global WAYFIND-R database. 

This poster describes how research is empowered by a seamless data flow and  research-ready data

Stone T., et al., Empowering research with seamless data flow and research-ready, anonymized data in OMOP CDM: Learnings from the design of WAYFIND-R, a global precision oncology registry and research platform.

OHDSI Europe Symposium 2024

WAYFIND-R Meet the Investigator Onsite Meeting at ESMO 2024

At this event, investigators can get an update on the current status of WAYFIND-R and meet other investigators from around the world who are involved in this major project.

This poster reports the first descriptive analysis of the global WAYFIND-R cohort

Blay J-Y., et al. WAYFIND-R: A global, real-world database of patients (pts) with a solid tumour profiled with next-generation sequencing (NGS).  

ESMO 2023, poster # 206P.

This poster describes socio-demographic and socio-economic characteristics of the global WAYFIND-R population

Hackshaw A., et al., WAYFIND-R: A Global, Real-World Precision Oncology Registry – Socioeconomic Features.  

ISPOR Europe 2023.

Launch of the WAYFIND-R Data Sharing and Collaboration Platform! 

The WAYFIND-R team is excited to announce the launch of the WAYFIND-R Data Sharing and Collaboration Platform. This platform provides the medical and scientific community with access to high-quality data and enables research collaborations to help advance precision oncology. 

This poster highlights the key features of the WAYFIND-R RWD Registry for Solid Tumors with NGS Testing

Le Tourneau, C., et al. WAYFIND-R: Delivering a high-quality real-world data (RWD) global registry of patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS),
AACR Annual Meeting 2022, poster #4094.

This poster conceptualizes the core variables within the WAYFIND-R registry and how it supports future research with a harmonized approach

Dienstmann, R., et al Conceptualization of core clinico-molecular variables for registries enrolling patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS),
 AACR Annual Meeting 2022, poster #5246.

This journal in the JCO Precision Oncology discusses the approach to solving the complex clinicogenomic data landscape in precision oncology and the learning from WAYFIND-R

Le Tourneau, C., et al. An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry.
JCO Precis Oncol. 2022;6:e2200019.